Press Releases Pangenomic Health Inc.

Equities

NARA

CA69842E3041

Delayed Canadian Securities Exchange Other stock markets 13:14:10 2024-06-25 EDT			5-day change	1st Jan Change
0.1 ^CAD	0.00%		+25.00%	-50.00%

05-27	Pangenomic Health Inc. announced that it has received CAD 1.075116 million in funding	CI
05-17	Pangenomic Health Inc. announced that it expects to receive CAD 1 million in funding	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

PanGenomic Health Provides Update on Management Cease Trade Order	05-28	AQ
PanGenomic Health Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements	04-12	AQ
PanGenomic Health Announces Completion of Consolidation	03-21	AQ
CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)	03-19	NE
PanGenomic Health Announces Proposed Consolidation and Completion of Withdrawal from AQSE	03-18	AQ
PanGenomic Health Announces Withdrawal from AQSE	02-20	AQ
PanGenomic Health Announces Changes to Board of Directors	02-16	AQ
PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility	01-09	AQ
PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry	12-06	AQ
How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way	11-22	NE
PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests	11-17	AQ
PanGenomic Health Intends to Close Shares for Debt Settlement	11-01	AQ
PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023	23-08-30	AQ
PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement	23-08-09	AQ
PanGenomic Health Announces Director Resignations	23-07-13	AQ
PanGenomic Health Subsidiary Launches Vitamin D Health Assessments and Announces Corporate Appointments	23-07-06	AQ
PanGenomic Health Provides Update for NARA Product and Conversational AI	23-06-06	AQ
PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform	23-05-30	AQ
PanGenomic Health Announces Financial Results for the 2022 Fiscal Year	23-05-02	AQ
PanGenomic Health Announces AGM Results	23-05-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pangenomic Health Inc.

Equities

NARA

CA69842E3041

Press Releases

Filters